Article abstract


Nature Cell Biology 10, 53 - 60 (2008)
Published online: 9 December 2007 | doi:10.1038/ncb1668



There is an Erratum (February 2008) associated with this Article.

Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation

Eric Metzger1, Na Yin1, Melanie Wissmann1, Natalia Kunowska1, Kristin Fischer1, Nicolaus Friedrichs2, Debasis Patnaik3, Jonathan M. G. Higgins3, Noelle Potier4, Karl-Heinz Scheidtmann5, Reinhard Buettner2 & Roland Schüle1


Posttranslational modifications of histones such as methylation, acetylation and phosphorylation regulate chromatin structure and gene expression. Here we show that protein-kinase-C-related kinase 1 (PRK1) phosphorylates histone H3 at threonine 11 (H3T11) upon ligand-dependent recruitment to androgen receptor target genes. PRK1 is pivotal to androgen receptor function because PRK1 knockdown or inhibition impedes androgen receptor-dependent transcription. Blocking PRK1 function abrogates androgen-induced H3T11 phosphorylation and inhibits androgen-induced demethylation of histone H3. Moreover, serine-5-phosphorylated RNA polymerase II is no longer observed at androgen receptor target promoters. Phosphorylation of H3T11 by PRK1 accelerates demethylation by the Jumonji C (JmjC)-domain-containing protein JMJD2C. Thus, phosphorylation of H3T11 by PRK1 establishes a novel chromatin mark for gene activation, identifying PRK1 as a gatekeeper of androgen receptor-dependent transcription. Importantly, levels of PRK1 and phosphorylated H3T11 correlate with Gleason scores of prostate carcinomas. Finally, inhibition of PRK1 blocks proliferation of androgen receptor-induced tumour cell proliferation, making PRK1 a promising therapeutic target.

Top
  1. Universitäts-Frauenklinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacherstrasse 66, 79106 Freiburg, Germany.
  2. Institut für Pathologie, Universitätsklinikum Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany.
  3. Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  4. Institut de Chimie LC3 – CNRS - UMR 7177, ISIS, 8 allée Gaspard Monge, 67083 Strasbourg, France.
  5. Institut für Genetik, Universität Bonn, Römerstrasse 16, 53117 Bonn, Germany.

Correspondence to: Roland Schüle1 e-mail: roland.schuele@uniklinik-freiburg.de



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Thrilling transcription through threonine phosphorylation

Nature Cell Biology News and Views (01 Jan 2008)


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges

  • Protect Enzyme from In Planta Degradation

    • Deadline: Jul 15 2009
    • Reward: $20,000 USD

    A proposal for stable expression of an enzyme in corn seed is desired.

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

natureproducts